As of Oct 05
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 45.00, with a high estimate of 54.00 and a low estimate of 41.00. The median estimate represents a +15.30% increase from the last price of 39.03.
The current consensus among 5 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.